REPEAT Study - Resistance to ErythroPoietin Effectiveness Algorithm Trial

PHASE3TerminatedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions
Kidney Failure, ChronicDrug Resistance
Interventions
DRUG

erythropoietin

Decrease dosage by 12.5% q 2 weeks according to an algorithm.

Trial Locations (7)

Unknown

Foothills Hospital, Calgary

St. Paul's Hospital, Vancouver

Memorial University Medical Centre, St. John's

Kingston General Hospital, Kingston

London Helath Sciences Centre, London

Humber River Regional Hosptial, Toronto

St. Michael's Hospital, Toronto

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Ortho Biotech, Inc.

INDUSTRY

lead

Queen's University

OTHER